CD19-PD1-CART Cell
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19-PD1-CART Cell, covering 2019-11-15 to 2019-11-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficiency Study of CD19-PD1-CART Cell in Relapsed/Refractory B Cell Lymphoma [Phase 2]